Opthea Limited

OPT's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

OPT Growth rates comparisons

Looking into Opthea Limited growth rates, revenue grew by 15 % in the fourth quarter of 2024 from the same quarter a year ago. Ranking at No. 213

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 12.11 %

Opthea Limited net loss increased from $-143 millions, to $-220 millions in fourth quarter of 2024,

• More on OPT's Growth

OPT's Valuation comparisons

Opthea Limited
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 24.4 in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.

Company

PE TTM

Industry

PE TTM

Company's Price to Sales ratio is at 17456.68.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 7.39.

• More on OPT's Valuation

Total Debt (Millions $)	-
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Revenue/Employee (TTM) $	1,861
Net Income/Employee (TTM) $	-
Receivable Turnover (TTM)	-
Tangible Book Value (Per Share $)	-0.12

OPT's Valuation comparisons

Opthea Limited
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 24.4 in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.

Company

PE TTM

Industry

PE TTM

Company's Price to Sales ratio is at 17456.68.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 7.39.

• More on OPT's Valuation

• Market Capitalization (Millions $)	2,176
• Shares Outstanding (Millions)	638
• Employees	67
• Revenues (TTM) (Millions $)	0
• Net Income (TTM) (Millions $)	-220
• Cash Flow (TTM) (Millions $)	89
• Capital Exp. (TTM) (Millions $)	0
• Total Debt (Millions $)	-
• Dividend TTM ($)	0 $
• Dividend Yield TTM (%)	-
• Revenue/Employee (TTM) $	1,861
• Net Income/Employee(TTM) $	-
• Receivable Turnover Ratio (TTM)	-
• Tangible Book Value (Per Share $)	-0.12

• Market Capitalization (Millions $)	2,176
• Shares Outstanding (Millions)	638
• Employees	67
• Revenues (TTM) (Millions $)	0
• Net Income (TTM) (Millions $)	-220
• Cash Flow (TTM) (Millions $)	89
• Capital Exp. (TTM) (Millions $)	0

	*Ratio*
• Capital Ratio (MRQ)	2.94
• Total Debt to Equity (MRQ)	-
• Tangible Leverage Ratio (MRQ)	-
• Asset Turnover Ratio (TTM)	0
• Inventory Turnover Ratio (TTM)	-

OPT's Profitability Comparisons

• More on OPT's Key Ratios

Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.